Tianhong Li
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC Study (NCT04552704) | Tianhong Li | 2020-10-30 |
Track Tianhong Li automatically
Every clearance here is in the API, with alerts when new ones post.